PubMed

Costs of lower-extremity ulcers among patients with diabetes.

Stockl K, Vanderplas A, Tafesse E, Chang E.

Diabetes Care. 2004 Sep;27(9):2129-34.PMID: 15333473 [PubMed - indexed for MEDLINE]Related articlesFree article

A cost analysis of diabetic lower-extremity ulcers.

Harrington C, Zagari MJ, Corea J, Klitenic J.

Diabetes Care. 2000 Sep;23(9):1333-8.PMID: 10977028 [PubMed - indexed for MEDLINE]Related articlesFree article

Costs and duration of care for lower extremity ulcers in patients with diabetes.

Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M.

Clin Ther. 1998 Jan-Feb;20(1):169-81. Erratum in: Clin Ther 1998 Mar-Apr;20(2):373. PMID: 9522113 [PubMed - indexed for MEDLINE]Related articles

Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.

Gandra SR, Lawrence LW, Parasuraman BM, Darin RM, Sherman JJ, Wall JL.

J Manag Care Pharm. 2006 Sep;12(7):546-54.PMID: 16981800 [PubMed - indexed for MEDLINE]Related articlesFree article

A staged management diabetes foot program versus standard care: a 1-year cost and utilization comparison in a state public hospital system.

Horswell RL, Birke JA, Patout CA Jr.

Arch Phys Med Rehabil. 2003 Dec;84(12):1743-6.PMID: 14669177 [PubMed - indexed for MEDLINE]Related articles

Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.

Khandker RK, Kruzikas DT, McLaughlin TP.

J Manag Care Pharm. 2008 Jun;14(5):426-41.PMID: 18597572 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting.

Apelqvist J, Ragnarson-Tennvall G, Larsson J, Persson U.

Foot Ankle Int. 1995 Jul;16(7):388-94.PMID: 7550950 [PubMed - indexed for MEDLINE]Related articles

A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis.

Jackson J, Fernandes AW, Nelson W.

Clin Ther. 2006 Sep;28(9):1462-71.PMID: 17062318 [PubMed - indexed for MEDLINE]Related articles

Severe sepsis in managed care: analysis of incidence, one-year mortality, and associated costs of care.

Braun L, Riedel AA, Cooper LM.

J Manag Care Pharm. 2004 Nov-Dec;10(6):521-30.PMID: 15548124 [PubMed - indexed for MEDLINE]Related articlesFree article

The quality of life and economic burden of neuropathy in diabetic patients in Germany in 2002--results from the Diabetic Microvascular Complications (DIMICO) study.

Happich M, John J, Stamenitis S, Clouth J, Polnau D.

Diabetes Res Clin Pract. 2008 Aug;81(2):223-30. Epub 2008 Jul 7.PMID: 18602714 [PubMed - indexed for MEDLINE]Related articles

Disease-related and all-cause health care costs of elderly patients with gout.

Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, Krishnan E.

J Manag Care Pharm. 2008 Mar;14(2):164-75.PMID: 18331118 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, Wagner EH.

Diabetes Care. 1999 Mar;22(3):382-7.PMID: 10097914 [PubMed - indexed for MEDLINE]Related articlesFree article

Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.

Bullano MF, Willey V, Hauch O, Wygant G, Spyropoulos AC, Hoffman L.

J Manag Care Pharm. 2005 Oct;11(8):663-73.PMID: 16194130 [PubMed - indexed for MEDLINE]Related articlesFree article

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

J Manag Care Pharm. 2007 Sep;13(7):561-9.PMID: 17874862 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of diabetic foot lesions in hospital: costs and benefits.

Benotmane A, Mohammedi F, Ayad F, Kadi K, Medjbeur S, Azzouz A.

Diabetes Metab. 2001 Dec;27(6):688-94.PMID: 11852378 [PubMed - indexed for MEDLINE]Related articlesFree article

An economic evaluation of the cost of diabetic foot ulcers: results of a retrospective study on 239 patients.

Girod I, Valensi P, Laforêt C, Moreau-Defarges T, Guillon P, Baron F.

Diabetes Metab. 2003 Jun;29(3):269-77.PMID: 12909815 [PubMed - indexed for MEDLINE]Related articlesFree article

Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged > or =65 years with rheumatoid arthritis.

Weycker D, Yu EB, Woolley JM, Oster G.

Clin Ther. 2005 May;27(5):646-56.PMID: 15978314 [PubMed - indexed for MEDLINE]Related articles

Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients.

Bickston SJ, Waters HC, Dabbous O, Tang BI, Rahman M.

J Manag Care Pharm. 2008 May;14(4):352-62.PMID: 18500913 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of health care costs in adults with diabetes.

Gilmer TP, O'Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, Solberg LI.

Diabetes Care. 2005 Jan;28(1):59-64.PMID: 15616234 [PubMed - indexed for MEDLINE]Related articlesFree article

Determining an episode of care using claims data. Diabetic foot ulcer.

Mehta SS, Suzuki S, Glick HA, Schulman KA.

Diabetes Care. 1999 Jul;22(7):1110-5.PMID: 10388976 [PubMed - indexed for MEDLINE]Related articlesFree article